Moleculin Biotech (MBRX)
(Delayed Data from NSDQ)
$3.42 USD
-0.08 (-2.29%)
Updated Jul 25, 2024 04:00 PM ET
Pre-Market: $4.00 +0.58 (16.96%) 9:20 AM ET
3-Hold of 5 3
D Value D Growth A Momentum D VGM
Cash flow Statements
Fiscal Year End for Moleculin Biotech, Inc falls in the month of December.
All data in Millions except Per Share data.
Cash Flow From Operations, Investments & Financial Activities
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
---|---|---|---|---|---|
Cash Flow From Operations, Investments & Financial Activities |
|||||
Net Income (Loss) | -29.77 | -29.03 | -15.89 | -17.36 | -13.21 |
Depreciation/Amortization & Depletion | 0.13 | 0.13 | 0.16 | 0.20 | 0.20 |
Net Change from Assets/Liabilities | 1.62 | 0.22 | 1.04 | -0.04 | -2.14 |
Net Cash from Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Operating Activities | 3.92 | 1.03 | -4.26 | -0.57 | -2.05 |
Net Cash From Operating Activities | -24.10 | -27.64 | -18.95 | -17.77 | -17.20 |
Property & Equipment | -0.12 | -0.07 | -0.02 | -0.37 | -0.05 |
Acquisition/ Disposition of Subsidiaries | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Investments | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Investing Activities | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Net Cash from Investing Activities | -0.12 | -0.07 | -0.02 | -0.37 | -0.05 |
Uses of Funds
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
---|---|---|---|---|---|
Issuance (Repurchase) of Capital Stock | 4.17 | 0.00 | 74.75 | 22.57 | 20.85 |
Issuance (Repayment) of Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Increase (Decrease) Short-Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Payment of Dividends & Other Distributions | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Financing Activities | 0.49 | -0.02 | -0.02 | -0.02 | 0.00 |
Net Cash from Financing Activities | 4.65 | -0.02 | 74.72 | 22.55 | 20.85 |
Effect of Exchange Rate Changes | -0.02 | -0.03 | -0.02 | 0.03 | 0.00 |
Net Change In Cash & Equivalents | -19.60 | -27.76 | 55.73 | 4.44 | 3.60 |
Cash at Beginning of Period | 43.15 | 70.90 | 15.17 | 10.74 | 7.13 |
Cash at End of Period | 23.55 | 43.15 | 70.90 | 15.17 | 10.74 |
Diluted Net EPS | -225.94 | -15.14 | -8.85 | -26.39 | -28.78 |
Fiscal Year End for Moleculin Biotech, Inc falls in the month of December.
All data in Millions except Per Share data.
Cash Flow From Operations, Investments & Financial Activities
6/30/2024 | 3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 | |
---|---|---|---|---|---|
Cash Flow From Operations, Investments & Financial Activities |
|||||
Net Income (Loss) | NA | -4.97 | -29.77 | -19.50 | -13.89 |
Depreciation/Amortization & Depletion | NA | 0.03 | 0.13 | 0.09 | 0.06 |
Net Change from Assets/Liabilities | NA | -0.93 | 1.62 | -1.59 | 0.87 |
Net Cash from Discontinued Operations | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Other Operating Activities | NA | -0.85 | 3.92 | 2.31 | 1.81 |
Net Cash From Operating Activities | NA | -6.72 | -24.10 | -18.69 | -11.14 |
Property & Equipment | NA | 0.00 | -0.12 | -0.04 | -0.02 |
Acquisition/ Disposition of Subsidiaries | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Investments | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Other Investing Activities | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Net Cash from Investing Activities | NA | 0.00 | -0.12 | -0.04 | -0.02 |
Uses of Funds
6/30/2024 | 3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 | |
---|---|---|---|---|---|
Issuance (Repurchase) of Capital Stock | NA | 0.00 | 4.17 | 0.21 | 0.21 |
Issuance (Repayment) of Debt | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Increase (Decrease) Short-Term Debt | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Payment of Dividends & Other Distributions | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Other Financing Activities | NA | 0.00 | 0.49 | -0.03 | -0.02 |
Net Cash from Financing Activities | NA | 0.00 | 4.65 | 0.19 | 0.19 |
Effect of Exchange Rate Changes | NA | -0.01 | -0.02 | -0.02 | -0.01 |
Net Change In Cash & Equivalents | NA | -6.73 | -19.60 | -18.57 | -10.97 |
Cash at Beginning of Period | NA | 23.55 | 43.15 | 43.15 | 43.15 |
Cash at End of Period | NA | 16.82 | 23.55 | 24.58 | 32.17 |
Diluted Net EPS | NA | -2.02 | -215.89 | -2.85 | -3.00 |